Quintiles Transnational (Q - Get Report): This clinical trial outsourcing company may be relatively unknown by Wall Street, but that's a good thing because the company has an excellent business model, Cramer said.
To read a full recap of "Mad Money" on CNBC, click here.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. -- Written by Scott Rutt in Washington, D.C. To email Scott about this article, click here: Scott Rutt Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC